![Sari Fishman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
Sari Fishman currently works at Can-Fite BioPharma Ltd., as Vice President-Business Development from 2017.
Dr. Fishman also formerly worked at OphthaliX, Inc., as Director-Clinical Affairs.
Dr. Fishman received her doctorate degree from Bar-Ilan University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01/01/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutials for the treatment of ophthalmic disorders | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutials for the treatment of ophthalmic disorders | Health Technology |
Bar-Ilan University
 Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Can-Fite BioPharma Ltd.
 Can-Fite BioPharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
